Brightspring Health Services Inc (BTSG) Stock Price & News

BTSG:NASDAQ

Brightspring Health Services Inc

$63.74

+0.13%

(+0.080) 1D

$63.74

0.00% (0.00)

After hours

Closed: Oct 9, 4:00:01 PM GMT-4 · USD

All symbols

	Symbol	Price	Change	% Change

Generating top insights for BTSG...

Open

$63.77

High

$65.09

Low

$63.50

Mkt. cap

12.61B

Avg. vol.

2.53M

Volume

1.61M

P/E ratio

38.49

52-wk high

$73.75

52-wk low

$27.30

EPS

$1.66

Shares outstanding

197.86M

No. of employees

24K

Open

$63.77

High

$65.09

Low

$63.50

Mkt. cap

12.61B

Avg. vol.

2.53M

Volume

1.61M

P/E ratio

38.49

52-wk high

$73.75

52-wk low

$27.30

EPS

$1.66

Shares outstanding

197.86M

No. of employees

24K

Related stocks

Twist Bioscience Corp

$159.78

+5.08%

SPCX

Space Exploration Technologies Corp

$162.57

+1.25%

CRDO

Credo Technology Group Holding Ltd

$216.55

+2.21%

News stories

From web sources and news partners

Trefis

1 day ago

6 Green Days In A Row: BrightSpring Health Services Stock Is Up 15%

https://www.dars.gov.et/

1 month ago

BrightSpring (BTSG) Results at a Glance: Profit Per Share Clears Its Benchmark in Latest Trading; Market Reaction

About Brightspring Health Services Inc

CEOJon B. Rousseau

Employees23.5K

Founded1974

HeadquartersLouisville, Kentucky, United States

SectorHealth care provider

Websitebrightspringhealth.com

Analyst	Recommendation	Action	Price target	Projected	Date
Sean Dodge BMO Capital	Buy	Reiterated	$70.00	+9.8%	10/02/2026
Unknown Analyst Jefferies	Buy	Maintained	$87.00	+36.5%	09/17/2026
A.J. Rice UBS	Buy	Maintained	$85.00	+33.4%	09/09/2026
Charles Rhyee TD Cowen	Buy	Reiterated	$81.00	+27.1%	08/19/2026
Pito Chickering Deutsche Bank	Buy	Reiterated	$70.00	+9.8%	08/03/2026
Erin Wright Morgan Stanley	Buy	Reiterated	$80.00	+25.5%	08/03/2026
Stephen Baxter Wells Fargo	Buy	Maintained	$78.00	+22.4%	08/03/2026
David Larsen BTIG	Buy	Maintained	$90.00	+41.2%	08/03/2026
Matthew Gillmor CFA KeyBanc	Buy	Maintained	$80.00	+25.5%	08/03/2026
Ann Hynes Mizuho Securities	Buy	Reiterated	$86.00	+34.9%	07/31/2026
Jared Haase William Blair	Buy	Reiterated	-	-	07/31/2026
Jason Cassorla Guggenheim	Buy	Reiterated	$81.00	+27.1%	07/31/2026
Scott Fidel Goldman Sachs	Buy	Maintained	$80.00	+25.5%	07/27/2026
Parker Snure Raymond James	Buy	Initiated	$80.00	+25.5%	07/10/2026
Kevin Fischbeck Bank of America Securities	Buy	Reiterated	$77.00	+20.8%	07/02/2026
Joanna Gajuk Bank of America Securities	Buy	Reiterated	$77.00	+20.8%	07/02/2026
Kyle Evans Stephens	Buy	Maintained	$64.00	+0.4%	05/04/2026
Raj Kumar CFA Stephens	Buy	Maintained	$64.00	+0.4%	05/04/2026
Whit Mayo Leerink Partners	Buy	Maintained	$49.00	-23.1%	03/02/2026

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	3.33B	3.55B	3.61B	3.87B
Cost of goods sold	2.94B	3.14B	3.13B	3.38B
Cost of revenue	2.94B	3.14B	3.13B	3.38B
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	304.16M	304.44M	360.77M	362.36M
Operating expense	304.16M	304.44M	360.77M	362.36M
Total operating expenses	3.25B	3.44B	3.49B	3.74B
Operating income	87.84M	108.11M	121.45M	130.39M
Other non operating income	-	-	-	-
EBT including unusual items	49.61M	69.58M	82.83M	93.51M
EBT excluding unusual items	49.61M	69.58M	82.83M	93.51M
Income tax expense	12.12M	20.03M	8.55M	6.91M
Effective tax rate	24.43%	28.78%	10.32%	7.39%
Other operating expenses	-	-	-	-
Net income	55.84M	77.08M	148.77M	84.29M
Net profit margin	1.67%	2.17%	4.12%	2.18%
Earnings per share	0.30	0.33	0.39	0.45
Interest and investment income	-	-	-	-
Interest expense	-38.24M	-38.54M	-38.62M	-36.88M
Net interest expenses	-38.24M	-38.54M	-38.62M	-36.88M
Depreciation and amortization charges	-	-	-	-
EBITDA	128.60M	147.64M	160.54M	171.81M
Gain or loss from assets sale	342.00K	573.00K	-	-

Finance

Ask anything